Society for Endocrinology - a world-leading authority on hormones

Europe approves AstraZeneca thyroid cancer drug (Reuters, 21 February 2012)

22 Feb 2012


The European Commission has approved vandetanib (Caprelsa) for patients with non-operable advanced medullary thyroid cancer.

Full article